*All the data provided above is for oil products only
In 2018, Epidiolex became the first ever cannabis-derived drug to be approved by the FDA in America. Today, we are giving you the lowdown on what it is, why it’s such a HUGE deal for the cannabis community, and what it’s used for.
Not only the first FDA-approved treatment for Dravet syndrome but also the first treatment with marijuana derivative – here is everything you should know about Epidiolex.
What is Epidiolex?
In mid-2018, the Food and Drug Administration, or FDA, approved Epidiolex, an oral solution of cannabidiol or CBD, which was designed as a treatment for seizures related to two rare and severe types of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome (also known as severe childhood myoclonic epilepsy). The medication was approved for patients older than 2 years of age.
In this way, Epidiolex became not only the first FDA-approved medicine for the treatment of patients with Dravet syndrome but also the first CBD-based medicine approved by the regulatory agency at all, representing a significant achievement for the industry, as well as the arrival to patients of a product of proven quality.
How Does Epidiolex Differ from “Regular” CBD Oils?
For a long time, families with children who suffer epilepsy have been looking for medications that help reduce children’s seizures. One of these options has been CBD-based drugs, so parents have been lobbying legislators for years to get these drugs legalized, a fight in which the legal marijuana industry has given its full support, and that with the success achieved in several states, has allowed thousands of people to help reduce and control their diseases and pains in the United States.
But none of these CBD-based products are approved by FDA as safe or even effective. All advertise alleged medical benefits that have no valid scientific or medical support, and even worse, few contain what their labels say, with cases of people poisoned by consuming unregulated CBD products or those that contain a synthetic cannabinoid.
This is the most crucial edge that Epidiolex has compared to other regular CBD oils on the market, as it has FDA approval for patients over two years of age, ensuring that it is safe for consumption and has clinical trials which demonstrate its positive effect in reducing epileptic seizures. Epidiolex is presented as an option that demonstrates its effectiveness in a market full of illegal products that lack FDA approval.
Is There an Ingredients List/Cannabinoid Profile for Epidiolex?
The positive effects that CBD has in mitigating pain and helping to control various diseases have been known for a long time. And thanks to this, 29 states have legalized the use of CBD-based medicines in order to help sufferers of certain conditions. The illegality that marijuana has at the federal level has made research difficult, so there is no precise profile to determine which list of ingredients is more or less effective in CBD-based medicines.
Thanks to this, the FDA’s approval of Epidiolex provides a secure foundation for the industry, which now has a model of safe and reliable CBD medicine to follow. As for the public, people now have access to a safe CBD mediation tested by the FDA’s rigorous process. Epidiolex thus becomes a model to follow for CBD-based medicines arising in the future.
Final Thoughts on Epidiolex
As advocates for all things cannabis, the news of Epidiolex’s approval came nothing short of celebratory for us. CBD users around the world suffering and struggling with rare forms of epilepsy could now access something life-changing – legally!
However, not everybody has gotten behind this new legal change – and we would love to know your thoughts in the comments. Are you for or against Epidiolex, and why?